|
|
| Neurologie > Etude de marché sectorielle |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2005 |
Taille du document : |
25 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Stakeholder Insight: Cognitive Impairment in Schizoaffective Disorder - Inevitable or Treatable? 259 pages | Octobre 2005 |
IntroductionCognitive impairment is regarded as a core deficit of schizophrenia; the primary unmet need is the availability of an effective drug for the treatment of cognitive impairment in schizophre |
12 920,00 €
|
| |
| |
Pipeline and Commercial Insight: Alzheimer's Disease - Beta treatments on the horizon 272 pages | Novembre 2005 |
IntroductionAlzheimer's patients remain poorly treated and are growing in number. Currently, cholinesterase inhibitors and the more recent NMDA-receptor antagonists provide only moderate and tempor |
19 380,00 €
|
| |
| |
World Sleep Disorders Market, 2004-2011 1 pages | Mars 2006 |
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Pipeline Insight: Anxiety Disorders - A decade of declining revenues 310 pages | Mars 2006 |
IntroductionThe global anxiety disorders market is set to decline from $4.5 billion in 2006 to $2.6 billion by 2015 (CAGR 200615 -6.0%). This will be primarily due to the launch of numerous generic |
9 120,00 €
|
| |
| |
Neurological Monitors Market, 1998-2008 1 pages | Mai 2006 |
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
MarketWatch: CNS 28 pages | Juillet 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analys |
160,00 €
|
| |
| |
MarketWatch: CNS 25 pages | Janvier 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analys |
160,00 €
|
| |
| |
New Drugs in Development for Alzheimer's Disease 1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
MarketWatch: CNS 29 pages | Mars 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analys |
160,00 €
|
| |
| |
MarketWatch: CNS 30 pages | Avril 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analys |
160,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the   CNS industry.
|
|
In this month’s MarketWatch…  
 
  This month's highlights   Page 2 - Key Announcements   Page 2 - CNS News Round-Up  
  Neurology   Page 4 - Opinion: Schwarz: lacosamide on track for dual approval…   Page 5 - Headlines   Page 5 - Alzheimer's Disease Update   Page 6 - Multiple Sclerosis Update   Page 7 - Parkinson's Disease Update  
  Psychiatry   Page 9 - Headlines   Page 9 - Depression Update   Page 11 - Behavioral Disorders Update  
  Pain   Page 13 - Headlines   Page 13 - R&D Update   Page 15 - Regulatory Update   Page 16 - Licensing & Collaborations Update  
  Company Spotlight   Page 18 - Forest Laboratories  
  Further Reading   Page 23  
 
  Index   Page 24 - Pharma companies   Page 24 - Biotech companies   Page 25 - Key Drugs  
|
|
|
PPLSEN
|
|
|
|
|